Funding · Company
Neuralink Corp.
Fremont, CABiotech & Pharma
Neuralink Corp. of Fremont, CA has disclosed $1.18B across 3 Form D offerings filed with the SEC between Aug 4, 2021 and Jun 12, 2025.
$1.18B
Total disclosed
3
Form D offerings
79
Open roles today
Hiring — 79 open roles as of Aug 8, 2026
Based in South San Francisco, California, United States, Austin, Texas, United States; South San Francisco, California, United States, Austin, Texas, United States. Counted from the company's own public job board.
Offerings on file
Each amount is as reported on that filing, cumulative across its own amendments. Newest first.
$323M
Form D · Nov 22, 2023 ↗
Q4 2023
· 1 amendment, first filed Aug 8, 2023
Filing details
HeadquartersFremont, CAIndustryBiotech & Pharma (Biotechnology)Incorporated2016SEC CIK0001708503Offerings on file3
Source: SEC Form D structured data. Amounts are self-reported by the issuer on a notice filing — not audited, and cumulative across amendments. The website link is resolved automatically and may be wrong — tell us if it is. Full methodology →